The vitamin D receptor agonist elocalcitol inhibits IL‐8‐dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF‐kB pathways
暂无分享,去创建一个
E. Sarchielli | G. Vannelli | L. Adorini | G. Laverny | A. Morelli | M. Gacci | M. Maggi | G. Penna | S. Amuchastegui | B. Fibbi | E. Colli | A. Chavalmane | Enrico Silvestrini | E. Corsiero